RALB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.533000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.002800E-01
Normal-vs-Stage2
3.633000E-01
Normal-vs-Stage3
9.538800E-01
Normal-vs-Stage4
3.324800E-01
Stage1-vs-Stage2
3.914800E-01
Stage1-vs-Stage3
8.439800E-01
Stage1-vs-Stage4
2.763400E-01
Stage2-vs-Stage3
3.333600E-01
Stage2-vs-Stage4
5.069600E-01
Stage3-vs-Stage4
3.028200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.679400E-01
Normal-vs-AfricanAmerican
4.485600E-01
Normal-vs-Asian
7.382200E-01
Caucasian-vs-AfricanAmerican
4.996200E-01
Caucasian-vs-Asian
1.304410E-01
AfricanAmerican-vs-Asian
3.835400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.364000E-01
Normal-vs-Female
4.879200E-01
Male-vs-Female
3.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.408000E-01
Normal-vs-Age(41-60Yrs)
2.261600E-01
Normal-vs-Age(61-80Yrs)
6.591400E-01
Normal-vs-Age(81-100Yrs)
2.843200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.018800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.758000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.035000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.986000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.244000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.308430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.740200E-01
Normal-vs-Daily Drinker
6.696800E-01
Normal-vs-Weekly Drinker
5.422600E-01
Normal-vs-Occasional Drinker
3.806000E-01
Normal-vs-Social Drinker
6.146400E-01
Non Drinker-vs-Daily Drinker
9.180600E-01
Non Drinker-vs-Weekly Drinker
9.009800E-01
Non Drinker-vs-Occasional Drinker
1.697620E-01
Non Drinker-vs-Social Drinker
8.925000E-01
Daily Drinker-vs-Weekly Drinker
9.825800E-01
Daily Drinker-vs-Occasional Drinker
1.970830E-01
Daily Drinker-vs-Social Drinker
9.727000E-01
Weekly Drinker-vs-Occasional Drinker
2.058400E-01
Weekly Drinker-vs-Social Drinker
9.885600E-01
Occasional Drinker-vs-Social Drinker
2.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.866200E-01
Normal-vs-Grade 2
2.049600E-01
Normal-vs-Grade 3
1.836810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.355200E-04
Grade 1-vs-Grade 3
3.954300E-04
Grade 1-vs-Grade 4
8.866200E-01
Grade 2-vs-Grade 3
3.728400E-01
Grade 2-vs-Grade 4
2.049600E-01
Grade 3-vs-Grade 4
1.836810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.799400E-01
Normal-vs-NonDiabetic
4.759000E-01
Diabetic-vs-NonDiabetic
5.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.381800E-01
Normal-vs-NoPancreatitis
5.055600E-01
Pancreatitis-vs-NoPancreatitis
7.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.463800E-01
Normal-vs-N1
3.405000E-01
N0-vs-N1
1.083160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.569770E-01
Normal-vs-TP53-NonMutant
9.220200E-01
TP53-Mutant-vs-TP53-NonMutant
7.67150000191563E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
